MarketPulse

capital raise

118 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Ispecimen Inc.

iSpecimen Raises $2.5M via Private Placement to Bolster Operations

$ISPC raises $2.5M through private placement at $5.12/share. Proceeds target working capital and marketing expansion.
ISPCprivate placementcommon stock
GlobeNewswire Inc.GlobeNewswire Inc.··Pharvaris N.V.

Pharvaris Raises $115M to Advance Rare Disease Pipeline

Pharvaris raises $115M through 3.87M share offering at $29.68 per share to advance oral angioedema treatments; Phase 3 data expected Q3 2026.
PHVSPhase 3 clinical trialFDA approval
BenzingaBenzinga··Im Cannabis Corp

IM Cannabis Raises $550K via Convertible Notes to Fund Operations

IM Cannabis ($IMCC) closes convertible note financing totaling $550,000 in gross proceeds to support general corporate purposes.
IMCCfinancingwarrants
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Avalo Therapeutics Raises $375M to Advance Hidradenitis Suppurativa Treatment

Avalo Therapeutics prices $375M offering of 19.73M shares at $17.75 each to fund Phase 3 development of hidradenitis suppurativa treatment abdakibart, closing May 7, 2026.
AVTXPhase 3 clinical trialpublic offering
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Aptera Motors to Showcase Solar EV Vision at May Investor Conference

$SEV to present at Emerging Growth Conference May 6, showcasing solar EV progress amid $8.7M Q4 loss and $17.1M 2026 capital raise.
SEVfinancial resultscapital raise
BenzingaBenzinga··Na

East Side Games Raises $3.5M Via Private Placement to Pay Down Debt

East Side Games Group ($EAGR) raises $3.5M through private placement at $0.11 per unit, with insider Derek Lew investing $1M to support turnaround strategy.
RYprivate placementwarrants
GlobeNewswire Inc.GlobeNewswire Inc.··Na

UTime Limited Raises $1.2M Through Direct Offering at $1.20 Per Share

UTime Limited raises $1.2M via registered direct offering of 1M shares at $1.20 per share, with closing expected May 4, 2026.
WTOcapital raiseregistered direct offering
BenzingaBenzinga··Sweta Killa

Seaport Therapeutics Eyes Nasdaq Debut With $255M IPO, Signaling Biotech Sector Momentum

Seaport Therapeutics raised $255 million through IPO priced at $18/share, beginning Nasdaq trading Friday as ticker $SPTX, amid growing biotech IPO momentum.
SFTBYAVEXXEIPObiotech
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Senseonics Raises $80M to Fund Eversense 365 Launch and Pipeline Expansion

Senseonics raises $80M through common stock and pre-funded warrant offering to fund Eversense 365 launch and pipeline development, closing May 4, 2026.
SENSpublic offeringcapital raise
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Rein Therapeutics Raises $50M via IPO to Fund Pulmonary Fibrosis Trial

Rein Therapeutics prices $50M stock offering at $1.00 per share to fund LTI-03 Phase 2 trial for idiopathic pulmonary fibrosis, with cash runway extended through 2028.
RNTXclinical trialpublic offering
GlobeNewswire Inc.GlobeNewswire Inc.··Fibrobiologics, Inc.

FibroBiologics Advances Clinical Pipeline With cGMP Manufacturing, Raises $3M

FibroBiologics completes cGMP manufacturing for lead candidate CYWC628, expects first patient dosing Q2 2026 in diabetic foot ulcer trial. Company raises $3M and maintains $1.5M cash.
FBLGcapital raisepreclinical results
BenzingaBenzinga··Frontier Lithium Inc.

Frontier Lithium Closes C$15M Financing to Advance Ontario Lithium Project

Frontier Lithium closes C$15M financing at C$0.75/unit to advance Ontario PAK Lithium Project, strengthening North American battery supply chains with Mitsubishi partnership.
MTSUYcapital raisecritical minerals
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Intellia Therapeutics Raises $180M in Stock Offering to Fuel CRISPR Pipeline

Intellia Therapeutics raises $180M via stock offering at $10.75/share to advance CRISPR gene-editing therapies, with lead underwriters Jefferies, Goldman Sachs, Citigroup.
REGNNTLApublic offeringcapital raise
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Oruka Therapeutics Raises $700M in Upsized Public Offering at $72.50 Per Share

Oruka Therapeutics prices 9.66M shares at $72.50 in upsized offering, raising $700.4M with potential additional proceeds from underwriter overallotment option.
ORKAmonoclonal antibodyclinical-stage
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Amesite Raises $7.8M Through Direct Offering to Bolster Working Capital

Amesite closes $7.8M concurrent offering at $1.435/share, with $2.6M upfront and up to $5.2M from warrant exercises.
AMSTprivate placementwarrant exercise
GlobeNewswire Inc.GlobeNewswire Inc.··Na

U-BX Technology Raises $4.55M via Direct Offering to Fund InsurTech Growth

U-BX Technology closes $4.55M registered direct offering, selling 15.17M units at $0.30 each to fund AI-driven insurtech growth and development.
UBXGartificial intelligencecapital raise
BenzingaBenzinga··Globe Newswire

Auddia Raises $12M in Public Offering to Fuel Growth Initiatives

Auddia raises $12M in public offering, selling 5.08M shares at $2.36 per share. Capital designated for working capital and corporate initiatives.
AUUDwarrantspublic offering
BenzingaBenzinga··Not Specified

Oruka Therapeutics Plans $500M Capital Raise via Public Offering

Oruka Therapeutics plans $500M public offering plus $75M underwriter option to fund monoclonal antibody pipeline for psoriasis and inflammatory conditions.
ORKAmonoclonal antibodypublic offering
BenzingaBenzinga··Prnewswire

Velo3D Raises $50M Through Direct Stock Offering to Fund Operations

Metal 3D printing firm Velo3D prices $50M registered direct offering at $14 per share, closing April 28, 2026.
VELOcommon stockcapital raise
The Motley FoolThe Motley Fool··Reuben Gregg Brewer

Lucid Stock Slides to 52-Week Lows Amid Production Delays and Shareholder Dilution

Lucid stock hits 52-week lows after missing Q1 targets due to supplier issues. Despite doubling 2025 production, the unprofitable EV maker continues shareholder dilution, signaling financial distress.
UBERLCIDprofitabilitycapital raise